FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/03/050376 [Registered on: 06/03/2023] Trial Registered Prospectively
Last Modified On: 03/03/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   This study is a comparison between Levobupivacaine and Ropivacaine in PNS guided supraclavicular brachial plexus block for upper limb surgeries  
Scientific Title of Study   Comparative Study Of Levobupivacaine Vs Ropivacaine In Peripheral Nerve Stimulator Guided Supraclavicular Brachial Plexus Block For Upper Limb Surgeries  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Yashasvini Lawania  
Designation  Post Graduate Resident  
Affiliation  PCMS AND RC, BHOPAL  
Address  Department Of Anaesthesia, PCMS And RC, Bhopal
Department Of Anaesthesia, PCMS And RC, Bhopal
Bhopal
MADHYA PRADESH
462001
India 
Phone  8989615497  
Fax    
Email  yashasvinilawania@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Abhilekh Jain  
Designation  Professor  
Affiliation  PCMS AND RC, BHOPAL  
Address  Department Of Anaesthesia, PCMS And RC, Bhopal
Department Of Anaesthesia, PCMS And RC, Bhopal
Bhopal
MADHYA PRADESH
462001
India 
Phone  9827606268  
Fax    
Email  jainabhilekh@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Yashasvini Lawania  
Designation  Post Graduate Resident  
Affiliation  PCMS AND RC, BHOPAL  
Address  Department Of Anaesthesia PCMS And RC Bhopal
Department Of Anaesthesia, PCMS And RC, Bhopal
Bhopal
MADHYA PRADESH
462001
India 
Phone  8989615497  
Fax    
Email  yashasvinilawania@gmail.com  
 
Source of Monetary or Material Support  
Peoples College Of Medical Sciences And Research Center, Bhopal  
 
Primary Sponsor  
Name  Dr. Yashasvini Lawania  
Address  Department Of Anaesthesia, PCMS And RC, Bhopal  
Type of Sponsor  Other [Self ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Yashasvini Lawania  Peoples College Of Medical Sciences And Research Centre   Department Of Anaesthesia, PCMS And RC, Bhopal
Bhopal
MADHYA PRADESH 
8989615497

yashasvinilawania@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Peoples college of medical sciences and research Institutional ethics committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: U072||COVID 19 virus not identified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Levobupivacaine  Levobupivacaine 0.5% 20cc volume is given in upper limb surgeries in supraclavicular brachial plexus block (within the nerve sheath)with the help of peripheral nerve stimulator and observation is done for sensory and motor blockade onset and duration before the surgery and post operatively observed for need of rescue analgesia. 
Comparator Agent  Ropivacaine   Ropivacaine is a long-acting amide local anaesthetic agent and first produced as a pure enantiomer. It produces effects similar to other local anaesthetics via reversible inhibition of sodium ion influx in nerve fibres. Ropivacaine 0.75% 20cc is given in upper limb surgeries in supraclavicular brachial plexus block(within the nerve sheath) with the help of perpheral nerve stimulator and observation is done for onset and duration of motor and sensory blockade onset and duration before the surgery and postoperatively observed for need of rescue analgesia. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA grades 1 And 2
Scheduled for elective upper limb surgeries under supraclavicular brachial plexus block  
 
ExclusionCriteria 
Details  - Patient’s refusal
- Age <18yrs and >60yrs.
- ASA grade 3 and more.
- History of serious pulmonary disease, ischemic heart disease, renal/hepaticdysfunction, coronary artery, or cervical spine disease and patients with abnormal coagulation profile.
- Patient with h/o opioid abuse.
- Patients with local skin site infections.
- Patients with hypersensitivity to any of the drugs used.
- Pregnant and lactating mothers.
- Failure of Block
- Restricted neck movement. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the efficacy of 0.5% Levobupivacaine vs 0.75% Ropivacaine in peripheral nerve stimulator guided supraclavicular brachial plexus block in upper limb surgeries   For first 24 hours in 5 mins, 10 mins, 20 mins, 30 mins, 1 hour, 2 hours, 4 hours, 6 hours, 12 hours and 24 hours  
 
Secondary Outcome  
Outcome  TimePoints 
To compare the side effects of 0.5% Levobupivacaine vs 0.75% Ropivacaine in peripheral nerve stimulator guided supraclavicular brachial plexus block for upper limb surgeries   First 24 hours in 5 mins, 10 mins, 15 mins, 20 mins, 30 mins, 1 hour, 2 hours, 4 hours, 6 hours, 12 hours and 24 hours  
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/03/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="1" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not Yet  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Various clinical trials have been done on the administration of Levobupivacaine vs Ropivacaine in neuraxial and peripheral nerve blocks for sensory and motor blockade. 
However, limited data is available on comparing Levobupivacaine vs Ropivacaine in brachial plexus block. Considering the low side effects and excellent postoperative analgesic efficacy of two drugs, it is essential to carry out a comparative evaluation of the two drugs. To compare the differences in Levobupivacaine and Ropivacaine for supraclavicular brachial plexus block would effect the sensory and motor blocks and duration of analgesia. The present work has been undertaken to study and compare the effect provided by Levobupivacaine vs Ropivacaine in supraclavicular brachial plexus block. 
 
Close